CSI Laboratories to expand new diagnostic laboratory in Alpharetta

CSI Laboratories®, a private national cancer diagnostic laboratory, today announced the lease of a new 65,000 square foot facility in Alpharetta, GA, located north of the city of Atlanta. CSI Laboratories is committing $15 million to its strategic expansion project, and this newly leased space will house its next generation laboratory, with clinical operations beginning in mid-2011. Fueled by strong demand for its personalized testing services, CSI Laboratories will utilize this new facility to achieve greater than a three-fold increase in laboratory capacity, medical offices, and administrative support.

“We have succeeded by providing exceptional customer service. This new facility expands our reach and allows us to become the testing partner of choice for pathologists and hospitals throughout the nation.”

Leading up to this expansion, CSI Laboratories has grown its medical team and executive leadership by recruiting top talent from around the country. Laboratory directors, Lawrence Hertzberg, M.D., Steve Kargas, M.D., Ph.D. and Theresa Brown, Ph.D., each left Genzyme Genetics to join CSI over the past three years. Keith Sharkey, VP of Sales and Marketing, came to the organization after serving in sales management roles with US LABS and GenPath / Bio-Reference Laboratories. Heather Creran, CSI's President and COO, joined the leadership team after serving in executive roles with Impath and Clarient.

CSI Laboratories offers a unique patient-centric approach to diagnostic care. Over the past three years, CSI has grown to become a premier provider of specialized testing. Demand for its core testing services in clinical flow cytometry, immunohistochemistry and diagnostic consultation has remained high. CSI Laboratories will continue to grow its employee base by 75-100 employees throughout its expansion. Ron Ghafary, CSI's founder, stated, "We have succeeded by providing exceptional customer service. This new facility expands our reach and allows us to become the testing partner of choice for pathologists and hospitals throughout the nation."

Dr. Hertzberg, CSI Laboratories' Medical Director, commented, "We at CSI understand the unique role that pathologists play in diagnostic care, and our new laboratory will provide additional opportunities to increase product offerings and capacity to support them in their routine practice."

Source : CSI Laboratories